Lin Wang News Today

99.1 Announcement on 2024/05/30: Important Resolutions from UMCs 2024 Annual General Meeting 99.2 Announcement on 2024/05/30: The Companys Re-election of directors at 2024...

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

A new study conducted by the Wilhelm Lab at the University of Oklahoma examines a promising development in biomedical nanoengineering. Published in Advanced Materials, the study explores new findings on the transportation of cancer nanomedicines into solid tumors.

Los Angeles CA (SPX) Mar 21, 2024 - Researchers at Penn State have unlocked the secrets of leafhoppers natural armor, revealing potential applications in optical technology and invisibility devices. The study, led by Tak-Sing Wong, a

Increased use of Paxlovid, the antiviral drug used to treat COVID-19, could prevent hundreds of thousands of hospitalizations and save tens of billions of dollars a year, according to a new epidemiological model published by researchers at The Univer

Increased use of Paxlovid, the antiviral drug used to treat COVID-19, could prevent hundreds of thousands of hospitalizations and save tens of billions of dollars a year, according to a new epidemiological model published by researchers at The University of Texas at Austin.

Epidemiologists found that treating even 20% of symptomatic cases would save lives and improve public health.

Walking in Wanhua: A Social Assembly is an art engagement in the communities and neighborhoods of Wanhua, Taipei, over the past three years.

YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company", and together with its subsidiaries, "YS Group"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the appointment of six new members to its Board of Directors (the "Board"), effective February 13, 2024. The six new directors are: ...

Disney Plus has canceled “American Born Chinese” after only one season despite it receiving stellar reviews from audiences and critics. Moving the news: A source familiar with the matter told Variety that Disney canceled “American Born Chinese” after the book-to-screen adaptation failed to receive the viewership needed to justify a second season. The recent development also came a day after the options on the cast expired, according to Deadline.